Position in PFE
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$183,311,335
-$24,270,289 QoQ
Shares Held
7,612,597
+3.0% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
1.63%
of 13F equity value
Holder Rank
#70
of 2,821 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Artemis Investment Management LLP holds $978,265,315 across 7 Drug Manufacturers - General names. PFE ranks #2 (18.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,279,269 | $242,574,987 | |
| 2 | PFE |
Pfizer Inc
This page
|
7,612,597 | $183,311,335 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
3,053,480 | $175,941,517 | |
| 4 | BIIB |
Biogen Inc.
|
570,974 | $123,364,642 | |
| 5 | ABBV |
AbbVie Inc.
|
482,591 | $121,439,199 | |
| 6 | LLY |
ELI LILLY & Co
|
95,948 | $115,082,919 | |
| 7 | JNJ |
Johnson & Johnson
|
65,168 | $16,550,716 |
All Filings in PFE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $183,311,335 | 7,612,597 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $207,581,624 | 7,392,508 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $139,686,012 | 5,609,880 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $15,051,978 | 590,737 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $16,935,082 | 698,642 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $14,803,780 | 584,206 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $11,887,456 | 448,076 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $13,316,075 | 460,127 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $10,062,587 | 359,635 | Shares | Sole | 2024-07-15 | |
| 2022-12-31 | $116,540,665 | 2,274,408 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $125,874,677 | 2,876,478 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $140,170,870 | 2,673,486 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $203,577,707 | 3,932,349 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $277,850,563 | 4,705,344 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $212,120,459 | 4,931,887 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $12,397,155 | 316,577 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $26,876,247 | 741,823 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $19,656,024 | 533,986 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $18,012,856 | 490,814 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $16,728,356 | 511,570 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $47,326,271 | 1,449,949 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||